• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on: "Is Adjuvant Therapy a Better Option for Esophageal Squamous Cell Carcinoma Patients Treated With Esophagectomy? A Prognosis Prediction Model Based on Multicenter Real-world Data".

作者信息

Shujie Huang, Sichao Wang, Zhen Gao, Guibin Qiao

机构信息

Department of Thoracic Surgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences Guangzhou, China.

Shantou University Medical College Shantou, China.

出版信息

Ann Surg. 2022 Dec 1;276(6):e1114. doi: 10.1097/SLA.0000000000005278. Epub 2021 Nov 9.

DOI:10.1097/SLA.0000000000005278
PMID:35129491
Abstract
摘要

相似文献

1
Comment on: "Is Adjuvant Therapy a Better Option for Esophageal Squamous Cell Carcinoma Patients Treated With Esophagectomy? A Prognosis Prediction Model Based on Multicenter Real-world Data".
Ann Surg. 2022 Dec 1;276(6):e1114. doi: 10.1097/SLA.0000000000005278. Epub 2021 Nov 9.
2
Response to Comment on: "Is Adjuvant Therapy a Better Option for Esophageal Squamous Cell Carcinoma Patients Treated With Esophagectomy? A Prognosis Prediction Model Based on Multicenter Real-world Data".对关于《辅助治疗对接受食管切除术的食管鳞状细胞癌患者是否是更好的选择？基于多中心真实世界数据的预后预测模型》评论的回复
Ann Surg. 2022 Dec 1;276(6):e1114-e1115. doi: 10.1097/SLA.0000000000005281. Epub 2021 Nov 9.
3
ASO Author Reflections: Prognostic Stratification and the Value of Adjuvant Therapy in Thoracic Esophageal Squamous Cell Carcinoma Patients After Esophagectomy.ASO作者反思：胸段食管鳞状细胞癌患者食管切除术后的预后分层及辅助治疗的价值
Ann Surg Oncol. 2019 Dec;26(Suppl 3):802-803. doi: 10.1245/s10434-019-07728-7. Epub 2019 Oct 25.
4
A Potential Indication for Adjuvant Therapy in Node-Negative Esophageal Squamous Cell Carcinoma.淋巴结阴性食管鳞状细胞癌辅助治疗的潜在指征
Ann Surg Oncol. 2020 Oct;27(11):4091-4092. doi: 10.1245/s10434-020-08846-3. Epub 2020 Jul 20.
5
Post-esophagectomy Adjuvant Chemotherapy Benefits Esophageal Cancer Patients.食管癌切除术后辅助化疗对食管癌患者有益。
In Vivo. 2019 Mar-Apr;33(2):501-506. doi: 10.21873/invivo.11502.
6
ASO Author Reflections: Tumor Response After the First Course of Neoadjuvant Chemotherapy Reflects Prognosis After Surgery in Patients with Esophageal Squamous Cell Carcinoma.ASO作者反思：食管鳞状细胞癌患者新辅助化疗第一疗程后的肿瘤反应反映手术预后
Ann Surg Oncol. 2024 Aug;31(8):5310-5311. doi: 10.1245/s10434-024-15371-0. Epub 2024 May 3.
7
Application of Pathological Staging in Esophageal Squamous Cell Carcinoma.病理分期在食管鳞状细胞癌中的应用。
Methods Mol Biol. 2020;2129:19-31. doi: 10.1007/978-1-0716-0377-2_3.
8
Validation of the post-neoadjuvant staging system of the American joint committee on cancer, 8th edition, in patients treated with neoadjuvant chemoradiotherapy followed by curative esophagectomy for localized esophageal squamous cell carcinoma.验证第 8 版美国癌症联合委员会的新辅助分期系统在接受新辅助放化疗后行根治性食管切除术治疗局限性食管鳞状细胞癌患者中的应用。
Surg Oncol. 2020 Dec;35:491-497. doi: 10.1016/j.suronc.2020.10.015. Epub 2020 Oct 24.
9
Minimal invasive versus open esophagectomy for patients with esophageal squamous cell carcinoma after neoadjuvant treatments.新辅助治疗后食管鳞状细胞癌患者的微创与开放食管切除术对比
BMC Cancer. 2021 Feb 9;21(1):145. doi: 10.1186/s12885-021-07867-9.
10
Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy.新辅助放化疗联合手术治疗食管鳞癌患者的复发模式和时间。
BMC Cancer. 2021 Nov 9;21(1):1192. doi: 10.1186/s12885-021-08918-x.